Fluorescently labeled chain-terminating nucleotides create detectable stopping points during DNA synthesis. Because each incorporated terminator carries a fluorescence signal, the resulting DNA fragments contain both length and labeling information. The instrument uses these signals after separation to infer nucleotide order, linking a chemical termination event to an automated sequence readout.
Capillary electrophoresis separates the synthesized DNA fragments according to size before detection. Fragments that differ in length reach the detection stage in an ordered pattern, while their fluorescence identifies the terminating nucleotide. This separation-and-detection step converts a mixture of products into a signal pattern that the instrument can interpret as a sequence.
Automation reduces the amount of manual handling between synthesis, fragment separation, and signal interpretation. A standardized instrument-based workflow can make analyses faster and more reproducible than a process dependent on repeated manual intervention. In cancer genomics studies, that consistency strengthens the efficiency and accuracy of genetic analysis across samples.
In tumor samples, the technique can reveal mutations and gene fusions, along with other genomic alterations detectable through genetic analysis. These findings help researchers examine the molecular features of cancers rather than relying only on broader sample characteristics. The resulting data can contribute to biomarker discovery and molecular classification of tumors.
Researchers can use automated sequencing to monitor treatment-related changes in tumor samples. Sequence information provides a way to examine whether detected genomic features differ as a study follows treatment. This application complements mutation and fusion identification, allowing cancer genomics projects to track changes rather than limiting analysis to a single baseline characterization.
Scalable workflows allow cancer genomics studies to extend automated genetic analysis across the samples or analyses required by a project while maintaining a consistent process. That combination of scale, reproducibility, and reduced manual intervention can improve study efficiency and strengthen accuracy. It is particularly relevant when researchers need systematic data for biomarker discovery or molecular classification.